new tirzepatide compound FDA Says Compounded Must Exit the Market led and built for women Compounded GLP-1 - Semaglutide &

Several doses of Novo Nordisk's Ozempic and Wegovy, both semaglutides, have been on the FDA's shortage list since early 2022

Additionally, long-term effects and potential risks associated with prolonged SERM use in wound healing applications are still not well understood

Gelling RW, Du XQ, Dichmann DS et al (2003) Lower blood glucose, hyperglucagonemia, and pancreatic cell hyperplasia in glucagon receptor knockout mice

Read our guide to staying hydrated on GLP-1 medications for practical questions to discuss with your provider

But you may not keep getting stronger

Diabetes Spectrum: A Publication of the American Diabetes Association, 34 (1), 7375